CHEST
Volume 161, Issue 2, February 2022, Pages e71-e73
Novel ReportAn Acute Exacerbation of Idiopathic Pulmonary Fibrosis After BNT162b2 mRNA COVID-19 Vaccination: A Case Report
Key Words
acute exacerbation
BNT162b2 mRNA COVID-19 vaccine
COVID-19
idiopathic pulmonary fibrosis
interstitial lung disease
Abbreviations
AE-IPF
acute exacerbation of IPF
DI=ILD
drug-induced ILD
ILD
interstitial lung disease
IPF
idiopathic pulmonary fibrosis
SAE
serious adverse event
Cited by (0)
FUNDING/SUPPORT: A. G. was supported by T32HL 007778. CR was supported by the Boehringer-Ingelheim IPF/ILD Discovery Award and K08HL151970-01. E. L. H. was supported by R01HL109233, R01HL125850, R01HL152677, and grants from the Gabriel and Alma Elias Research Fund and the Greenfield Foundation.
© 2021 Published by Elsevier Inc under license from the American College of Chest Physicians.